Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 3, 2025
Surrogacy4All Seeks Compassionate Women to Become Egg Donors and Help Families Grow: Reimbursed to $15,000 per donation
EIN Presswire
·
April 3, 2025
Surrogacy4All Seeks Compassionate Women to Become Egg Donors and Help Families Grow: Reimbursed to $15,000 per donation. All ethnic groups welcome! NEW YORK, NY, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- Surrogacy4All Seeks Compassionate Women …
Employment opportunities: Surrogacy4All Seeks Compassionate Women to Become Surrogates and Help Build Families
EIN Presswire
·
April 3, 2025
Surrogacy4All Seeks Compassionate Women to Become Surrogates and Help Build Families NEW YORK, NY, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- Surrogacy4All Seeks Compassionate Women to Become Surrogates and Help Build Families in USA/Canada …
Alice Khalkad House of Skin Launches State-of-the-Art Spa, Ushering in a New Era of Skincare Excellence
EIN Presswire
·
April 3, 2025
A dazzling evening of glamour and innovation in skincare. ROSLYN, NY, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- Alice Khalkad, medical aesthetician and founder, proudly unveiled the highly anticipated Alice Khalkad House of Skin spa, marking a …
1800Wheelchair Leads Electric Wheelchair Market Boom
EIN Presswire
·
April 3, 2025
1800Wheelchair leads the growing electric wheelchair market with innovative, user-focused mobility solutions that meet demand. NY, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- A trusted leader in mobility solutions since 1997, it is spearheading …
Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s …
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 3, 2025
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points Educational Symposium Focuses on Advancing GBS Care and …
Anne Whitaker Appointed as Non-Executive Director
GlobeNewswire
·
April 3, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive Director (NED) based in the United …
Praxis Precision Medicines to Participate in Upcoming April Conferences
GlobeNewswire
·
April 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
April 3, 2025
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results and provide a …
Theratechnologies annoncera ses résultats financiers du premier trimestre de l’exercice financier de 2025 et fera une mise à jour de ses activités
GlobeNewswire
·
April 3, 2025
MONTRÉAL, 03 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la Société dévoilera ses résultats financiers …
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 3, 2025
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising Approximately $17.0 Million -- …
Vaxil: Management and Operational Update
GlobeNewswire
·
April 3, 2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities, …
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
April 3, 2025
EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological …
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
GlobeNewswire
·
April 3, 2025
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million upfront payment and expand dataset to combination therapy New interim data for the vebreltinib development …
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
GlobeNewswire
·
April 3, 2025
VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial launch of Cohealyx™, a collagen-based …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 3, 2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on April 1, 2025, it awarded …
I-Mab Reports Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
April 3, 2025
Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first givastomig Phase 1b dose expansion cohort; …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Best SARMs For Cutting, Bulking & Muscle Growth 2025: Top Fat Loss Sarms Stack For Sale On The Market - CrazyBulk
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Welcome to the world of SARMs, the selective androgen receptor modulators that have gained popularity in the fitness and bodybuilding community. SARMs offer a unique approach to enhancing muscle growth, …
HealthRecon Connect Achieves ISO 22301:2019 Certification for Business Continuity Management
GlobeNewswire
·
April 3, 2025
DALLAS, April 03, 2025 (GLOBE NEWSWIRE) -- HealthRecon Connect is proud to announce that it has been awarded the ISO 22301:2019 certification, an internationally recognized standard for Business Continuity Management Systems (BCMS). This achievement …